Annual Report 2022

CONSOLIDATED STATEMENT OF FINANCIAL POSITION At 31 December 2022 46 The United Laboratories International Holdings Limited Annual Report 2022 2022 2021 NOTES RMB’000 RMB’000 Non-current liabilities Deferred tax liabilities 30 194,069 172,309 Deferred income in respect of government grants 26 & 33 43,413 55,319 Lease liabilities 28 3,896 7,125 Borrowings – due after one year 29 1,095,789 221,212 1,337,167 455,965 10,609,431 9,339,908 Capital and reserves Share capital 31 16,965 17,125 Reserves 10,591,121 9,323,367 Equity attributable to owners of the Company 10,608,086 9,340,492 Non-controlling interests 1,345 (584) Total equity 10,609,431 9,339,908 The consolidated financial statements on pages 43 to 157 were approved and authorised for issue by the Board of Directors on 21 March 2023 and are signed on its behalf by: TSOI HOI SHAN LEUNG WING HON DIRECTOR DIRECTOR

RkJQdWJsaXNoZXIy NTk2Nzg=